HelixNano

Using mRNA to modify biology at the push of a button

First Investment: 2017

HelixNano is developing new ways to manipulate messenger RNA, the molecule that delivers information from genes to the cell’s protein factories. One of HelixNano’s advances makes mRNA vaccines more targeted and more powerful; the company is using this technique to advance a mutation-resistant, second-generation vaccine against the SARS-CoV‑2 virus that causes Covid-19.

Explore Companies

Syntax Bio

Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics

Using state-of-the-art machine learning models to create custom-build protein drugs

Equilibrium Energy

Developing a grid optimization trading platform

Impulse Space

Opening access to space beyond Low Earth Orbit